Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9670221 Furopyridines as bromodomain inhibitors

Patent 9670221 was granted and assigned to GlaxoSmithKline on June, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

GlaxoSmithKline

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

96702210

Patent Inventor Names

John Alexander Brown0

Rino Antonio Bit0

Susan Marie Westaway0

Tracy Jane Shipley0

Christopher Roland Wellaway0

Dominique Amans0

Matthew Campbell0

Matthew J. Lindon0

...

Date of Patent

June 6, 2017

Patent Application Number

147709220

Date Filed

March 12, 2014

Patent Citations Received

‌

US Patent 11890275 Therapeutic compounds

Patent Primary Examiner

Emily Bernhardt

Patent abstract

The present invention relates to novel compounds, pharmaceutical compositions containing such compounds and to their use in therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9670221 Furopyridines as bromodomain inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API